Cargando…
Efficacy, Safety and Future Perspectives of JAK Inhibitors in the IBD Treatment
Although development of biologics has importantly improved the effectiveness in inducing and maintaining remission in inflammatory bowel disease (IBD), biologic therapies still have several limitations. Effective, low-cost drug therapy with good safety profile and compliance is therefore a substanti...
Autores principales: | Dudek, Patrycja, Fabisiak, Adam, Zatorski, Hubert, Malecka-Wojciesko, Ewa, Talar-Wojnarowska, Renata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658230/ https://www.ncbi.nlm.nih.gov/pubmed/34884361 http://dx.doi.org/10.3390/jcm10235660 |
Ejemplares similares
-
CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation
por: Wlodarczyk, Barbara, et al.
Publicado: (2023) -
Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy
por: Sochal, Marcin, et al.
Publicado: (2021) -
COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
por: Kubas, Aleksandra, et al.
Publicado: (2022) -
Clinical and Laboratory Characteristics of Anaemia in Hospitalized Patients with Inflammatory Bowel Disease
por: Woźniak, Małgorzata, et al.
Publicado: (2023) -
Clinical Significance of Erythroferrone and Bone Morphogenetic Protein-6 in Patients with Anemia in the Course of Inflammatory Bowel Disease
por: Woźniak, Małgorzata, et al.
Publicado: (2023)